Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00077233
Status:
TERMINATED
Last Update Posted:
2018-05-16
First Post:
2004-02-10
Brief Title:
FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Alliance for Clinical Trials in Oncology
Organization Data
Organization:
Alliance for Clinical Trials in Oncology
Class:
OTHER
Study ID:
CALGB 80203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eli Lilly and Company | INDUSTRY |
| National Cancer Institute NCI | NIH |
| Bristol-Myers Squibb | INDUSTRY |